Project/Area Number |
12470436
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Surgical dentistry
|
Research Institution | Mie University |
Principal Investigator |
INUI Madoka Mie University, Medicine, Associate Professor, 医学部, 助教授 (70159961)
|
Co-Investigator(Kenkyū-buntansha) |
MURATA Taku Mie University, Medicine, instructor, 医学部附属病院, 助手 (80242965)
NOMURA Zouji Mie University, Medicine, assitant Professor, 医学部附属病院, 講師 (80172815)
|
Project Period (FY) |
2000 – 2002
|
Project Status |
Completed (Fiscal Year 2002)
|
Budget Amount *help |
¥11,500,000 (Direct Cost: ¥11,500,000)
Fiscal Year 2002: ¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 2001: ¥2,800,000 (Direct Cost: ¥2,800,000)
Fiscal Year 2000: ¥6,800,000 (Direct Cost: ¥6,800,000)
|
Keywords | β_2-microglobulin / apoptosis / melanoma cell / Pl-3 kinase / Bcl-2 family / Novel apoptotic pathway / beta2 microglobulin / 腫瘍増殖因子 / 等電点蛋白分取電気泳動 |
Research Abstract |
In the present study, we purified the growth-inhibitory factors released by cultured MMN9 melanoma cells and identified one factor to be β_2-microglobulin (β_2M). Exogenous b2M induced apoposis in all melanoma cell lines tested but not normal fibroblasts. Thus, β_2M is a pro-apoptotic factor. The general caspase inhibitor Z-VAD-fmk and the caspase-3/-7 inhibitor DEVD-CHO did not block β_2M-induced apoptosis, indicating β_2M-induced apoposis does not involve the caspase-dependent pathway that characterizes the classical Fas-mediated apoptosis. Furthermore, bcl-2 expression did not alter during β_2M-induced apoptosis and the cleaved bcl-2 band that appears during Fas-mediated apoptosis of MMN9 cells was never observed. However, expression of the pro-apoptotic bax and bak molecules was upregulated later in β_2M-induced apoptosis. Thus, β_2M-induced apoptosis may involve bak- and bax-dependent apoptotic pathways. The morphological features of β_2M-induced apoptosis are similar to those observed in apoposis induced by the antibody ligation of MHC I molecules. In addition, like MHC I ligation-induced apoptosis, PI-3 kinase was activated at an early stage of β_2M-induced apoptosis and the PI-3 kinase inhibitor wortmannin blocked this apoptosis. Thus, β_2M-induced apoptosis of MMN9 melanoma cells may involve a signal sent through the MHC I molecule that activates PI-3 kinase, which in turn activates the bcl-2 oncoprotein family at a later stage of apoptosis. Understanding the apoptotic pathway induced by β_2M may suggest useful therapeutic strategies that aim to eliminate melanoma cells.
|